Vantage Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $7.19M | Buy |
173,003
+7,622
| +5% | +$317K | 1.51% | 25 |
|
|
2018
Q2 | $5.69M | Buy |
165,381
+6,213
| +4% | +$214K | 1.38% | 31 |
|
|
2018
Q1 | $5.36M | Sell |
159,168
-11,736
| -7% | -$395K | 1.36% | 30 |
|
|
2017
Q4 | $5.87M | Buy |
170,904
+10,699
| +7% | +$368K | 1.35% | 23 |
|
|
2017
Q3 | $5.43M | Buy |
160,205
+6,276
| +4% | +$213K | 1.4% | 23 |
|
|
2017
Q2 | $4.91M | Buy |
153,929
+48,963
| +47% | +$1.56M | 1.42% | 29 |
|
|
2017
Q1 | $3.41M | Buy |
104,966
+18,318
| +21% | +$595K | 1.12% | 34 |
|
|
2016
Q4 | $2.67M | Buy |
86,648
+2,692
| +3% | +$83K | 1.08% | 35 |
|
|
2016
Q3 | $2.7M | Buy |
83,956
+8,537
| +11% | +$274K | 1.2% | 31 |
|
|
2016
Q2 | $2.52M | Buy |
75,419
+1,757
| +2% | +$58.6K | 1.06% | 30 |
|
|
2016
Q1 | $2.07M | Buy |
73,662
+16,377
| +29% | +$460K | 0.92% | 33 |
|
|
2015
Q4 | $1.75M | Buy |
57,285
+5,878
| +11% | +$180K | 0.88% | 34 |
|
|
2015
Q3 | $1.53M | Buy |
51,407
+1,896
| +4% | +$56.5K | 0.86% | 33 |
|
|
2015
Q2 | $1.58M | Sell |
49,511
-40,618
| -45% | -$1.29M | 0.87% | 32 |
|
|
2015
Q1 | $2.98M | Buy |
90,129
+43,408
| +93% | +$1.43M | 0.84% | 36 |
|
|
2014
Q4 | $1.38M | Buy |
46,721
+9
| +0% | +$266 | 0.78% | 34 |
|
|
2014
Q3 | $1.31M | Sell |
46,712
-2,675
| -5% | -$75.1K | 0.8% | 35 |
|
|
2014
Q2 | $1.39M | Buy |
49,387
+867
| +2% | +$24.4K | 0.85% | 35 |
|
|
2014
Q1 | $1.48M | Buy |
48,520
+4,712
| +11% | +$144K | 0.98% | 33 |
|
|
2013
Q4 | $1.27M | Buy |
+43,808
| New | +$1.27M | 0.87% | 36 |
|